Insulin prices, availability and affordability in 13 low-income and middle-income countries

84Citations
Citations of this article
161Readers
Mendeley users who have this article in their library.

Abstract

Introduction Globally, one in two people needing insulin lack access. High prices and poor availability are thought to be key contributors to poor insulin access. However, few studies have assessed the availability, price and affordability of different insulin types in low-income and middle-income countries in a systematic way. Methods In 2016, 15 insulin price and availability surveys were undertaken (using an adaptation of the WHO/Health Action International medicine price and availability measurement methodology) in Brazil, China (Hubei and Shaanxi Provinces), Ethiopia, Ghana, India (Haryana and Madhya Pradesh States), Indonesia, Jordan, Kenya, Kyrgyzstan, Mali, Pakistan, Russia (Kazan Province) and Uganda. Data were collected in three sectors (public, private pharmacies and private hospitals/clinics) in three regions per survey. Insulin prices were standardised to 10 mL 100 IU/mL in US dollars (). Data were also collected for four comparator medicines. Results Mean availability was higher for human (55%-80%) versus analogue insulins (55%-63%), but only short-acting human insulin reached 80% availability (public sector). Median government procurement prices were 5 (human insulins) and 33 (long-acting analogues). In all three sectors, median patient prices were 9 for human insulins. Median patient prices for analogues varied between the public sector (34) and the two private sectors (44). Vials were cheaper than pens and cartridges. Biosimilars, when available, were mostly cheaper than originators. A low-income person had to work 4 and 7 days to buy 10 mL human and analogue insulin, respectively. For isophane human insulin, only three countries meet the WHO target of 80% availability of affordable essential medicines for non-communicable diseases in any sector. Conclusion Improving insulin availability and affordability needs to be addressed through national and global actions, including prioritising the supply of more affordable human insulin, increasing competition through the use of lower priced quality-assured biosimilars, negotiating lower prices from manufacturers and improving distribution systems.

References Powered by Scopus

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

656Citations
N/AReaders
Get full text

Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study

142Citations
N/AReaders
Get full text

Access to care for patients with insulin-requiring diabetes in developing countries: Case studies of Mozambique and Zambia

135Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

443Citations
N/AReaders
Get full text

Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas

144Citations
N/AReaders
Get full text

The Future of the Corporation and the Economics of Purpose

131Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ewen, M., Joosse, H. J., Beran, D., & Laing, R. (2019). Insulin prices, availability and affordability in 13 low-income and middle-income countries. BMJ Global Health, 4(3). https://doi.org/10.1136/bmjgh-2019-001410

Readers over time

‘19‘20‘21‘22‘23‘24‘25010203040

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 46

63%

Researcher 18

25%

Lecturer / Post doc 5

7%

Professor / Associate Prof. 4

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 20

36%

Social Sciences 13

24%

Pharmacology, Toxicology and Pharmaceut... 11

20%

Nursing and Health Professions 11

20%

Article Metrics

Tooltip
Mentions
News Mentions: 8
Social Media
Shares, Likes & Comments: 53

Save time finding and organizing research with Mendeley

Sign up for free
0